Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Cistanche tubulosa has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Echinacoside is not a separate ingredient so much as the marker constituent that defines a Cistanche extract. Its full biosynthetic route in C. tubulosa has been mapped, including de novo production in engineered systems. An extract's echinacoside percentage is therefore the meaningful specification. Where a label states only Cistanche extract with no glycoside figure, the material is not characterised.
Polyphenols such as echinacoside donate electrons and become phenoxyl radicals, which ascorbate can reduce back to the parent compound. This recycling is well characterised for the polyphenol-ascorbate pair generally. It is a chemical relationship measured in solution and in cell systems, not a demonstrated clinical outcome for this combination. Read it as mechanistic.
Echinacoside and acteoside are glycosides, so intestinal bacteria and brush-border glucosidases determine which metabolites actually enter circulation. In APP/PS1 mice, Cistanche tubulosa glycosides acted partly through gut microbial modulation. This means the response to a given oral dose depends on the person's microbiome, which is one reason inter-individual variation is likely. The animal finding does not establish that a probiotic co-supplement changes outcomes in people.
Rhodiola's salidroside is itself a phenylethanoid glycoside, structurally related to the Cistanche glycosides but simpler. The two herbs are commonly combined in fatigue-directed formulas. Direct combination data is absent, so this rests on category convention and a shared structural class rather than a tested interaction.
Cistanche has a long record in Chinese materia medica as a tonic herb, frequently formulated alongside ginseng. Ginsenosides and phenylethanoid glycosides are unrelated chemical classes acting by different routes. The pairing is historical formulation practice. No controlled trial has evaluated the combination.
The catechol moiety on echinacoside and acteoside is a strong metal-binding group, the same feature that makes catechol-containing polyphenols reduce non-heme iron absorption from a meal. Concentrated Cistanche extracts taken alongside an iron supplement would be expected to lower iron uptake to some degree. The magnitude has not been measured for this extract specifically. Spacing the doses avoids the question.
Nothing specific on file for Cistanche tubulosa. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 8 we read for Cistanche tubulosa. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.